MacLeod will succeed current CFO Andrew Galligan, who is set to retire, but will remain on with the company during a transition period as MacLeod takes over. Galligan spent 10 years at Nevro, according to a news release.
“I’m very pleased to join Nevro and I view this as an exciting opportunity to continue to build a great company while helping patients who suffer from chronic pain,” MacLeod said in the release. “I look forward to working closely with Keith and the rest of the Nevro team to execute on the Company’s growth strategy.”
Prior to taking on this new role, the 25-year veteran of financial and executive leadership roles in healthcare and technology spent 16 years at Stryker (NYSE:SYK). He served as VP of finance at Stryker Endoscopy and, before that, controller for the same division. MacLeod held other financial roles at United Airlines and Arthur Andersen & Co.
“Rod is a proven leader with a track record of success in finance and operations leadership,” Nevro chairman, president & CEO D. Keith Grossman said. “We are pleased that Rod is joining the Nevro executive team at a point in our history where his extensive financial, strategic and industry experience will help us accelerate toward long-term sustainable growth and strong financial performance for our shareholders.”